Your browser doesn't support javascript.
loading
GnRH Agonist and hCG (Dual Trigger) Versus hCG Trigger for Final Oocyte Maturation in Expected Normal Responders With a High Immature Oocyte Rate: Study Protocol for a Randomized, Superiority, Parallel Group, Controlled Trial.
Yan, Meng-Han; Cao, Jing-Xian; Hou, Jin-Wei; Jiang, Wen-Jing; Wang, Dan-Dan; Sun, Zhen-Gao; Song, Jing-Yan.
Afiliação
  • Yan MH; The College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
  • Cao JX; The First Clinical College, Shandong University of Traditional Chinese Medicine, Jinan, China.
  • Hou JW; The First Clinical College, Shandong University of Traditional Chinese Medicine, Jinan, China.
  • Jiang WJ; The First Clinical College, Shandong University of Traditional Chinese Medicine, Jinan, China.
  • Wang DD; The First Clinical College, Shandong University of Traditional Chinese Medicine, Jinan, China.
  • Sun ZG; The First Clinical College, Shandong University of Traditional Chinese Medicine, Jinan, China.
  • Song JY; Reproductive Center of Integrated Medicine, The Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.
Front Endocrinol (Lausanne) ; 13: 831859, 2022.
Article em En | MEDLINE | ID: mdl-35418945
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Medicinas Tradicionais: Medicinas_tradicionales_de_asia / Medicina_china Assunto principal: Síndrome de Hiperestimulação Ovariana / Gonadotropina Coriônica Tipo de estudo: Clinical_trials / Guideline Idioma: En Revista: Front Endocrinol (Lausanne) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Medicinas Tradicionais: Medicinas_tradicionales_de_asia / Medicina_china Assunto principal: Síndrome de Hiperestimulação Ovariana / Gonadotropina Coriônica Tipo de estudo: Clinical_trials / Guideline Idioma: En Revista: Front Endocrinol (Lausanne) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China